US 10548889
Compositions of CXCR4 inhibitors and methods of preparation and use
granted A61KA61K31/47A61K31/4709
Quick answer
US patent 10548889 (Compositions of CXCR4 inhibitors and methods of preparation and use) held by X4 Pharmaceuticals, Inc. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/47, A61K31/4709, A61K9/485, A61K9/4858